Loading
Latest filing published 07 Aug 2026 for Entera Bio Ltd.. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Yonatan Malca (board member) discloses dealings in Entera Bio Ltd. to SEC (Form 4). The record holds 6 filings, for trades running from 13 January 2022 to 7 August 2026.
Purchases make up the whole of the open-market record (1 purchase, €17k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. The rest of the record consists of 5 share grants.
The newest entry dates from 7 August 2026: a share grant, in Entera Bio Ltd. The most recent open-market purchase was published on 18 January 2022, 1,734 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations